Hypolipidaemic and anti-atherosclerotic effects of lupin proteins in a rabbit model

被引:50
|
作者
Marchesi, Marta [1 ]
Parolini, Cinzia [1 ]
Diani, Erika [1 ]
Rigamonti, Elena [1 ]
Cornelli, Lorena [1 ]
Arnoldi, Anna [2 ]
Sirtori, Cesare R. [1 ]
Chiesa, Giulia [1 ]
机构
[1] Univ Milan, Dept Pharmaceut Sci, I-20133 Milan, Italy
[2] Univ Milan, Dept Agrifood Mol Sci, I-20133 Milan, Italy
关键词
Lupinus albus; Protein isolates; Cholesterol; Atherosclerosis; Rabbits;
D O I
10.1017/S000711450894215X
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The biological activities of a protein isolate from lupin (Lupinus albus) were studied in a rabbit model of atherosclerosis. Focal plaque development was induced at both common carotid arteries by perivascular injury. After surgery. animals were fed three different diets for 90d, all with 1% cholesterol. 15 % SFA and 20 % protein: the protein source was casein (CAS), lupin proteins (LUP) or 50 % CAS + 50 % LUP (CAS + LUP). Lower cholesterolaemia was detected in the LUP v. the CAS group at 60 and 90 d of treatment (- 40.3 and - 33-5 %, respectively; P<0-05). Cryosection analyses of the carotids indicated a significant reduction in focal lesion progression in the LUP v. the CAS group (-37.4%; P<0.05). In summary. in a rabbit model of atherosclerosis. a protein isolate from L. albus reduced cholesterolaemia and exerted a remarkable protective activity against atherosclerosis progression.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 50 条
  • [41] PROSTACYCLIN ANALOGS AS ANTI-ATHEROSCLEROTIC DRUGS
    OREKHOV, AN
    TERTOV, VV
    SMIRNOV, VN
    LANCET, 1983, 2 (8348): : 521 - 521
  • [42] Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit
    Kaber, G.
    Kaiser, B.
    Baumgaertel-Allekotte, D.
    Rauch, B. H.
    Nossmann, S.
    Heim, K. H.
    Weber, A. A.
    Nagy, N.
    Fischer, J. W.
    Schroer, K.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (2B) : 561 - 569
  • [43] The potential anti-xanthoma and anti-atherosclerotic effects of proton pump inhibitors
    Namazi, M. R.
    Sharifian, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (06) : 579 - 580
  • [44] TRAPIDIL - A POTENTIAL ANTI-ATHEROSCLEROTIC AGENT
    SAUNDERS, RN
    HANDLEY, DA
    HAEMOSTASIS, 1982, 12 (1-2) : 67 - 67
  • [45] Anti-atherosclerotic mechanisms of statin therapy
    Babelova, Andrea
    Sedding, Daniel G.
    Brandes, Ralf P.
    CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (02) : 260 - 264
  • [46] NATURAL PRODUCTS FOR ANTI-ATHEROSCLEROTIC THERAPY
    Kirichenko, T.
    Orekhova, V.
    Myasoedova, V.
    Melnichenko, A.
    Sobenin, I.
    Orekhov, A.
    ATHEROSCLEROSIS, 2019, 287 : E152 - E152
  • [47] ARTIFICIAL HDL AS AN ANTI-ATHEROSCLEROTIC DRUG
    OREKHOV, AN
    MISHARIN, AY
    TERTOV, VV
    KHASHIMOV, KA
    POKROVSKY, SN
    REPIN, VS
    SMIRNOV, VN
    LANCET, 1984, 2 (8412): : 1149 - 1150
  • [48] ASTAXANTHIN: AN ANTI-ATHEROSCLEROTIC TREATMENT IN MICE
    Anto-Michel, N.
    Maechler, H.
    Zirlik, A.
    ATHEROSCLEROSIS, 2023, 379
  • [49] New trends in anti-atherosclerotic agents
    Napoli, C
    Sica, V
    Pignalosa, O
    de Nigris, F
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (15) : 1755 - 1772
  • [50] CETABEN SODIUM, AN ANTI-ATHEROSCLEROTIC AGENT
    ALBRIGHT, JD
    SCHAFFER, SA
    SHEPHERD, RG
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (07) : 936 - 937